Abstract
Prion disease represents a group of transmissible neurodegenerative disorders that include scrapie in sheep and goats, bovine spongiform encephalopathy (BSE), and Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru in humans. The disease is characterized clinically by ataxia, dementia, and myoclonus as well as pathologically by spongiosis, astrocytic gliosis, and neuronal loss (reviewed in refs. 1 and 2). CJD occurs mostly (about 85% of all cases) as sporadic cases (unknown etiology), with the rest of the cases being familial (owing to inheritance of mutations in the prion protein gene) or iatrogenic (due to accidental transmission during medical procedure). Recently, a new variant form of CJD (vCJD) has emerged in the United Kingdom that may originate from the BSE epidemic (3).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Prusiner, S. B. (1991) Molecular biology of prion diseases. Science 252, 1515–1522.
Prusiner, S. B. (1997) Prion diseases and the BSE crisis. Science 278, 245–251.
Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C. L., Gowland, I., Collinge, J., et al. (1997) The same prion strain causes vCJD and BSE. Nature 389, 448–450.
Cohen, F. E. and Prusiner, S. B. (1998) Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67, 793–819.
Brown, D. R., Qin, K., Herms, J. W., Madlung, A., Manson, J., Strome, R., Fraser, P. E., et al. (1997) The cellular prion protein binds copper in vivo. Nature 390, 684–687.
Mouillet-Richard, S., Ermonval, M., Chbassier, C., Laplanche, J. L., Lehmann, S., Launay, J. M., and Kellermann, O. (2000) Signal transduction through prion protein. Science 289, 1925–1928.
Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., Burlingame, A. L., and Prusiner, S. B. (1993) Structural studies of the scrapie prion protein using mass spectrom-etry and amino acid sequencing. Biochemistry 32, 1991–2002.
Meyer, R. K., McKinley, M. P., Bowman, K. A., Braunfeld, M. B., Barry, R. A., and Prusiner, S. B. (1986). Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA 83, 2310–2314.
Bassen, R. A. and Marsh, R. F. (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68, 7859–7868.
Chen, S. G., Teplow, D. B., Parchi, P., Teller, J. K., Gambetti, P., and Autilio-Gambetti, L. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270, 19173–19180.
Monari, L., Chen, S. G., Brown, P., Parchi, P., Petersen, R. B., Mikol, J., Gray, F., et al. (1994) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc. Natl. Acad. Sci. USA 91, 2839–2842.
Parchi, P., Castellani, R., Capellari, S., Ghetti, B., Young, K., Chen, S. G., et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39, 767–778.
Parchi, P., Capellari, S., Chen, S. G., Petersen, R. B., Gambetti, P., Kopp, N., et al. (1997) Typing prion isoforms. Nature 386, 232–234.
Parchi, P., Chen, S. G., Brown, P., Zou, W., Capellari, S., Budka, H., et al. (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc. Natl. Acad. Sci. USA 95, 8322–8327.
Parchi, P., Zou, W., Wang, W., Brown, P., Capellari, S., Ghetti, B., et al. (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc. Natl. Acad. Sci. USA 97, 10,168–10,172.
McKinley, M. P., Bolton, D. C., and Prusiner, S. B. (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57–62.
Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., et al. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61, 3688–3693.
Castellani, R., Parchi, P., Stahl, J., Capellari, S., Cohen, M., and Gambetti, P. (1996) Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies. Neurology 46, 1690–1693.
Castellani, R. J., Parchi, P., Madoff, L., Gambetti, P., and McKeever, P. (1997) Biopsy diagnosis of Creutzfeldt-Jakob disease by western blot: a case report. Hum. Pathol. 28, 623–626.
Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., et al. (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phe-notypic analysis of 300 subjects. Ann. Neurol. 46, 224–233.
Bolton, D. C., Bendheim, P. E., Marmorstein, A. D., and Potempska, A. (1987) Isolation and structural studies of the intact scrapie agent protein. Arch. Biochem. Biophys. 258, 579–590.
Chen, S. G., Parchi, P., Brown, P., Capellari, S., Zou, W., Cochran, E. J., et al. (1997) Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat. Med. 3, 1009–1015.
Stimson, E., Hope, J., Chong, A., and Burlingame, A. L. (1999). Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatog-raphy/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 38, 4885–4895.
Chen, S. G., Zou, W., Parchi, P., and Gambetti, P. (2000) PrPSc typing by N-terminal sequencing and mass spectrometry. Arch. Virol. 16(Suppl), 209–216.
Caughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F., and Caughey, W. S. (1991) Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infra-red spectroscopy. Biochemistry 30, 7672–7680.
Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., et al. (1993) Conversion of α-helices into β-sheets features in the formation of he scrapie prion pro-teins. Proc. Natl. Acad. Sci. USA 90, 10,962–10,966.
Safar, J., Roller, P. P., Gajdusek, D. C., and Gibbs, C. J., Jr. (1993) Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci. 2, 2206–2216.
Caughey, B., Raymond, G. J., and Bessen, R. A. (1998) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 273, 32,230–32,235.
Kitamoto, T., Shin, R. W., Doh-ura, K., Tomokane, N., Miyazono, M., Muramoto, T., and Tateishi, J. (1992) Abnormal isoform of prion proteins accumulates in the synaptic struc-tures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 140, 1285–1294.
Hilton, D. A., Fathers, E., Edwards, P., Ironside, J. W., and Zajicek, J. (1998). Prion immu-noreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352, 703–704.
Hill, A. F., Butterworth, R. J., Joiner, S., Jackson, G., Rossor, M. N., Thomas, D. J., et al. (1999). Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183–189.
European Commission (1999) The evaluation of tests for the diagnosis of transmissible spongiform encephalopathy in bovines. (see Website: http://europa.eu.int/comm/food/fs/bse12en.html)
Bieschke, J., Giese, A., Schulz-Schaeffer, W., Zerr, I., Poser, S., Eigen, M., and Kretzschmar, H. (2000). Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl. Acad. Sci. USA 97, 5468–5473.
Saborio, G. P., Permanne, B., and Soto, C. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810–813.
Center for Disease Control and Prevention (1999). Biosafety in Microbiological and Bio-medical Laboratories (BMBL), 4th Ed., Section VII-D: Prions. (see Website: http:// www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4s7d.htm)
Baron, H., Safar, J., Groth, D., DeArmond, S. J., and Prusiner, S. B. (1999) Biosafety issues in prion diseases, in Prion Biology and Diseases. (Prusiner, S. B., ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, pp. 743–777.
Tateishi, J., Tashima, T., and Kitamoto, T. (1991) Practical methods for chemical inactiva-tion of CJD pathogen. Microbiol. Immunol. 35, 163–166.
Budka, H., Aguzzi, A., Brown, P., Brucher, J. M., Bugiani, O., Gullotta, F., et al. (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 5, 459–466.
Ironside, J. W., Head, M. W., Bell, J. E., McCardle, L., and Will, R. G. (2000) Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 37, 1–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Zou, W., Colucci, M., Gambetti, P., Chen, S.G. (2003). Characterization of Prion Proteins. In: Potter, N.T. (eds) Neurogenetics. Methods in Molecular Biology™, vol 217. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-330-5:305
Download citation
DOI: https://doi.org/10.1385/1-59259-330-5:305
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-990-2
Online ISBN: 978-1-59259-330-9
eBook Packages: Springer Protocols